|
The 14th Cell Biology Industry Congress
The 14th CBIC Beijing Cell Biology Industry Conference was grandly held in Beijing from November 13th to 15th. During the conference, we conducted in-depth discussions with users and developers on topics including technological development, instrument R&D, pricing strategy, and future prospects. The conference focuses on cutting-edge fields such as cell therapy, stem cell research and application, exosome technology, regenerative medicine, anti-aging medicine, organoid models, tumor immunotherapy, and CGT (Cell and Gene Therapy) drug development & clinical translation. It features comprehensive sharing and demonstrations covering process development, technological innovation, clinical application, drug R&D, industrial transformation, commercialization strategies, and laws & regulations. We invite you to jointly explore new trends and opportunities in the cell biology field and promote high-quality industrial development. Clinical professionals: Physicians and physician assistants from clinical departments such as Hematology, Cell Therapy, Immunotherapy, Clinical Laboratory Medicine, Oncology, Orthopedics, and Dermatology; Academic and regulatory experts: Professors, scholars, and researchers from universities, research institutions, and regulatory/application authorities; R&D practitioners: Researchers specializing in exosome technology; Industry professionals: Staff from CGT pharmaceutical companies, CROs (Contract Research Organizations), CMOs (Contract Manufacturing Organizations), ACRPs (Association of Clinical Research Professionals), cell banks, animal research institutes, key laboratories, and CMC (Chemistry, Manufacturing, and Controls) development fields; Stakeholders: Decision-makers from suppliers and distributors of cell biologics and chemical drugs, as well as investment and financing institutions.
Domestic and international cell therapy institutions Cell therapy, stem cell and regenerative medicine diagnosis & treatment services, precision therapy services, anti-aging medical management, medical testing, clinical application, biological products, etc.; Instruments, equipment, and consumables Liquid nitrogen tanks, centrifuges, bioreactors, reagents, culture media, mass spectrometry systems, filtration devices, laboratory chambers/shakers, etc.; Technical service solutions Biochips, flow cytometry testing, cytokines, cell drug resistance testing, animal models, cell storage, cold chain logistics, smart factory informatization technology, etc.; Drug registration process development CROs, CMOs, CS0s (Contract Service Organizations), clinical research organizations, GMP production, protein purification and separation, etc.; CMC process development and quality control Efficacy evaluation, sterilization/cleaning, sterile laboratories, automated culture equipment, animal serum, high-throughput screening platforms, cell preparations, etc.; Organoid culture and organ models Organ-on-a-chip R&D, disease models, functional organoids, 3D bioprinting technology, drug sensitivity screening, biomaterials, nanotechnology, detection and imaging equipment, etc.
|
|
